Bexagliflozin

(Brenzavvy)

Bexagliflozin

Drug updated on 10/30/2023

Dosage FormTablet (oral; 20 mg)
Drug ClassSodium-glucose co-transporter 2 (SGLT2) inhibitors
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.